A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
Kowalski, Mark, Guindon, Jacinthe, Brazas, Louise, Moore, Celine, Entwistle, Joycelyn, Cizeau, Jeannick, Jewett, Michael A.S, MacDonald, Glen C
Published in The Journal of urology (01.11.2012)
Published in The Journal of urology (01.11.2012)
Get full text
Journal Article